1999
DOI: 10.1038/sj.bmt.1702070
|View full text |Cite
|
Sign up to set email alerts
|

Intravesical rhGM-CSF for the treatment of late onset hemorrhagic cystitis after bone marrow transplant

Abstract: Summary:In the present study, we assessed the clinical effect of recombinant human granulocyte-macrophage colonystimulating factor (rhGM-CSF) in the treatment of refractory, grade III-IV hemorrhagic cystitis (HC) in six patients who underwent bone marrow transplantation (BMT). These were four males and two females, aged 24-40 years (median age 30.5 years). All received allogeneic BMT from HLA-identical siblings after preparation with busulfan-cyclophosphamide. HC was evident 24.5 days (range 15-33 days) after … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
12
0

Year Published

2003
2003
2024
2024

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(12 citation statements)
references
References 25 publications
0
12
0
Order By: Relevance
“…18 Intravesicular sodium hyaluronate or recombinant human epidermal growth factor are other local treatment choices but need to be tested in larger cohorts of patients. 22,24 Recombinant human GM-CSF in intravesical instillation has been reported to be successful for the treatment of HC, 23 and we treated our patients with intravesical instillation of GM-CSF after HC onset, but no effective result was observed.…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…18 Intravesicular sodium hyaluronate or recombinant human epidermal growth factor are other local treatment choices but need to be tested in larger cohorts of patients. 22,24 Recombinant human GM-CSF in intravesical instillation has been reported to be successful for the treatment of HC, 23 and we treated our patients with intravesical instillation of GM-CSF after HC onset, but no effective result was observed.…”
Section: Discussionmentioning
confidence: 98%
“…[14][15][16][17] The use of formalin, alum, prostaglandin E1, estrogens, FVIIa, factor XIII, hyperbaric oxygen treatment, intravesicular sodium hyaluronate, recombinant human epidermal growth factor or recombinant human GM-CSF has been described, but their efficacy remains controversial. [18][19][20][21][22][23][24][25][26][27] Severe HC may also require surgical treatment with cystoscopy and cauterization, and even cystectomy when previous methods have failed, 28 but it is limited by the disadvantage of operation.…”
Section: Introductionmentioning
confidence: 99%
“…6 --9 Patients with viral infection may be treated with anti-viral agents, but their efficacy is limited. 8,9 Hyperbaric oxygen (HBO) may benefit patients with BK virus (BKV) -associated HC after HSCT. 5,10 --16 HBO has been shown effective in the treatment of radiation-induced HC, 17 --19 by promoting fibroblast proliferation and capillary angiogenesis, decreasing edema and facilitating damaged hypoxic urothelium.…”
Section: Introductionmentioning
confidence: 99%
“…Other therapeutic strategies used have included local instillation of prostaglandin, phenol, alum, formalin, estrogens, epidermal growth factor and recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF). 4,5 If a viral infection is detected, the administration of antiviral agents is indicated. 6 Hyperbaric oxygen therapy has been associated with a few successes.…”
mentioning
confidence: 99%